255.96 USD
▼-14.37-5.32%
盘后 256.05 +0.04%
2026-11-19
市值
$16.59B
市盈率
16.61
EPS
15.23
股息率
—
52 周区间
203.80 – 282.15
成交量
970.40K
Beta
0.48
目标价
315.18
52W 低 203.8052W 高 282.15
价格走势
公司简介
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing o...